Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line

Laryngoscope

Volumn 110, Issue 6, 2000, Pages 928-933

  DeFatta, Robert J ^a   Nathan, Cherie Ann O ^a   De Benedetti, Arrigo ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Angiogenic factors; Antisense RNA; Cell lines; Gene therapy; Head and neck cancer; Translation initiation factor eIF4E; Tumorigenicity

Indexed keywords

COMPLEMENTARY RNA; FIBROBLAST GROWTH FACTOR 2; INITIATION FACTOR 4E; VASCULOTROPIN;

ARTICLE; CANCER INHIBITION; CARCINOGENICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISOME; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0034120713     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200006000-00007     Document Type: Article

References (18)

1. Kerekatte V, Smiley K, Hu B, Smith A, Gelder F, De Benedetti A. The proto-oncogene/translation initiation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer 1995;64:27-31.
2. Rosenwald IB, Chen JJ, Wang S, Savas L, London IM, Pullman J. Upregulation of protein synthesis initiation factor eIF4E is an early event during colon carcinogenesis. Oncogene 1999;18:2507-2517.
3. Nathan CO, Liu L, Li B, Abreo F, Nandy I, De Benedetti A. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 1997;15:579-584.
4. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 1990;345:544-547.
5. Kevil C, Carter P, Hu B, De Benedetti A. Translational enhancement of FGf-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogens 1995;11:2339-2348.
6. Kevil C, De Benedetti A, Payne KD, Coe LL, Laroux S, Alexander S. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 1996;65:785-790.
7. Nathan CO, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer. J Clin Oncol 1999;17:1-6.
8. Franklin S, Pho T, Abreo F, et al. Detection of the proto-oncogene eFI4E in larynx and hypopharynx cancers. Arch Otolaryngol Head Neck Surg 1999;125:177-182.
9. Melton DA. Current Communications in Molecular Biology: Antisense RNA and DNA. New York: Cold Spring Harbor Laboratory, 1988:1-149.
10. De Benedetti A, Joshi-Barve S, Rinker-Schaeffer CW, Rhoads RE. Expression of antisense RNA against initiation factor 4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF4E and the p220 component of eIF-4F. Mol Cell Biol 1991;11:5435-5445.
11. Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG, Rhoads RE. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 1993;55:841-847.
12. De Benedetti A, Harris A. eIF4E Expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 1999;31:59-72.
13. Nathan CO, Franklin S, Abreo, FW, et al. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis. Laryngoscope 1999;109:1253-1258.
14. Sonenberg N. Translational Control. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1996:245-269.
15. Scott P, Smith K, Poulsom A, De Benedetti A, Bicknell R, Harris A. Differential expression of vascular endothelial growth factor mRNA versus protein isoforms expression in human breast cancer and relationship to eIF4E. Br J Cancer 1998;77:2120-2128.
16. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993;69:508-517.
17. Rousseau D, Gingras AC, Pause A, Sonenberg N. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 1996;13:2415-2420.
18. Sorrells E, Ghali G, De Benedetti A, Nathan CO, Li BD. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers. J Oral Maxillofac Surg 1999;57:294-299.